CAPN5-related vitreoretinopathy

An autosomal dominant vitreoretinopathy caused by variants in the CAPN5 gene. Additional features, such as developmental delay and hypotonia, have been reported in some patients.

Also known as: proliferative vitreoretinopathy, ADNIV, CAPN5 vitreoretinopathy, VRNI, autosomal dominant neovascular inflammatory vitreoretinopathy, retinitis proliferans, vitreoretinopathy, neovascular inflammatory, vitreoretinopathy, neovascular inflammatory, autosomal dominant

21 clinical trials for this condition and its sub-types.